Rare diseases
Investigational molecules
Locations
Back to Czechia13 clinical trials in Příbram, Czechia. Every trial is listed in the EU Clinical Trials Register and updated daily.
Our site in CzechiaKlinickeTesty.cz(opens in a new tab)CzechiaCzechiaCzechiaCzechiaCzechiaCzechiaCzechiaCzechiaCzechiaCzechiaCzechiaCzechiaThe busiest research cities in the country
What the registry says about research in the country
Innovative research focusing on atherosclerotic cardiovascular disease (ASCVD) prevention through new therapeutic approaches. Studies aim to reduce the risk of cardiovascular death, heart attacks, and strokes in high-risk populations.
Current trials evaluate novel medications targeting improved cardiovascular outcomes in patients with established vascular disease.
Comprehensive studies in atrial fibrillation management, comparing different therapeutic approaches for preventing cardioembolic events. Research focuses on both established and innovative anticoagulation strategies.
These trials aim to enhance safety and efficacy in managing irregular heart rhythms while preventing complications.
Advanced research investigating new treatments for dyslipidemia, focusing on reducing LDL cholesterol levels. Studies examine innovative approaches to managing abnormal lipid profiles and preventing cardiovascular complications.
The research aims to develop more effective therapeutic options for patients with lipid disorders and associated cardiovascular risks.
Tell us about your condition – we search every trial in Europe and connect you with the right site.
